Patent Assignment
Reel/Frame 015486/0573
Corrective Assignment to Correct the 1ST Assignor's Name. Document Previously Recorded on Reel 014681 Frame 0988. Assignor Hereby Confirm the Assignment of the Entire Interest.
Recorded: 2004-06-21
Pages: 12
Assignors
BOREA, PIER ANDREA
Executed: 2003-09-19
BARALDI, PIER GIOVANNI
Executed: 2003-09-19
CHEN, SHIH-FONG
Executed: 2003-11-03
LEUNG, EDWARD
Executed: 2003-09-22
Assignee
KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
CENTREGREEN TWO, SUITE 300, 4000 CENTREGREEN WAY, CARY, NORTH CAROLINA, 27513
Covered Property
(1)
Enhancing treatment of MDR cancer with adenosine A3 antagonists
Application:
10/603,406 →
Publication:
US 2004/0067932
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 12, 2003
From: BOREA L, PIER ANDREA; BARALDI, PIER GIOVANNI; CHEN, SHIH-FONG; LEUNG, EDWARD
To: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT,INC.
Reel/Frame 014681/0988 →
Security Agreement
Dec 30, 2008
From: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0870 →
Release of Security Interest
May 11, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0022 →